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INTRODUCTION
Helicobacter pylori is a Gram-negative spiral-shaped
bacterium that colonizes the human stomach and duo-
denum, despite the relative inhospitable gastric environ-
ment to the majority of bacteria (Lamarque and Peek
Jr, 2003; Stoicov et al., 2004). Chronic gastric infection
by H. pylori may originate various gastric-related
diseases such as chronic gastritis, peptic ulceration and
gastric cancer. Most colonized individuals (approxi-
mately 80%) remain asymptomatic, presenting mild
but diffuse inflammation of the stomach, showing little
or no atrophy throughout their lifetimes indicating
that the bacterium and the host adapt to each other
through a long-term equilibrium (Blaser and Atherton,
2004; Joseph and Kirschner, 2004). On the other hand,
there are those individuals that are chronically infected
and develop severe disease such as adenocarcinoma
(Joseph and Kirschner, 2004).
A combination of therapeutic agents has been used
in the eradication of H. pylori: (a) triple therapy with
the antibiotics metronidazole, tetracycline or amoxicillin
and bismuth; (b) double therapy constituted by anti-
biotics jointly with proton-pump inhibitors (omeprazole)
or with H2-blockers (ranitidine). The resistance to
metronidazole, in about 20% of patients especially
those already treated with metronidazole, and the high
side effect profile (headache, dizziness, nausea, diarrhea,
pseudomembraneous colitis, mycosis, sore mouth and
tongue, drug hypersensitivity and paraesthesia) are real
problems of the triple therapy. The results of the double
therapy on H. pylori eradication are also inconsistent
(Pakodi et al., 2000). Along with the development of
resistance to antibiotics there are other factors that
contribute to therapeutic failure: cost and efficacy of
antibiotics regarding the pH (for instance, amoxicillin
is most active at a neutral pH and tetracycline has
greater activity at a low pH (Wang and Huang, 2005).
Many naturally occurring compounds found in the
dietary and medicinal plants, herbs and fruit extracts
have been reported to possess antimicrobial activities
(Lin et al., 2005; Li et al., 2005; Wang and Huang, 2005;
Chun et al., 2005). For instance, recent research has
demonstrated that resveratrol produced during wine
fermentation is active in acidic conditions (e.g. in stom-
ach) and may be linked to inhibition of H. pylori (Lin
et al., 2005). Green tea catechins (epigallocatechin and
epicatechin) have been shown to inhibit the growth
of H. pylori in a guinea-pig model of infection (Stoicov
et al., 2004). In some cases, flavonoids and isoflavonoids
present in ethanol extracts of some plants were revealed
to possess potent anti-H. pylori activities (Fukai et al.,
2002; Li et al., 2005). Generally, flavonoids have a range
of biological activities and pharmacological effects,
including also a pronounced antiulcerogenic activity
(Motilva et al., 1992). The activity of essential oils against
Helicobacter pylori was reported (Ohno et al., 2003)
and amongst the 13 essential oils tested for H. pylori
growth inhibition, Cymbopogon citratus (lemongrass)
and Lippia citriodora (lemon verbena) were demon-
strated to have the highest bactericidal activities even
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The essential oil of Dittrichia viscosa subsp. revoluta and its fractions were assessed for anti-Helicobacter
activity. The essential oil was isolated by hydrodistillation, submitted to flash column chromatography and
analysed by gas chromatography, gas-chromatography coupled to mass spectrometry and 13C-nuclear magnetic
resonance. The anti-Helicobacter activity was determined by incorporation of the crude essential oil and
oxygenated fractions of the oil into the culture medium. At a concentration of 0.025 μL/mL no recovery was
registered when one of the oxygenated fractions of the oil, mainly constituted by 3-methoxy cuminyl isobutyrate
(about 40%), was used. This fraction revealed a higher activity against the six H. pylori strains tested when
compared with the other oxygenated fractions. The crude essential oil at a concentration of 0.33 μL/mL
reduced the initial population of H. pylori CCUG 15818 of 8.52 ± 0.30 log10 cfu/mL to 7.67 ± 0.22 log10 cfu/mL.
The susceptibility of several Helicobacter pylori strains to the oxygenated fraction of Dittrichia viscosa subsp.
revoluta essential oil suggests the possible use of these natural products in combating this widespread infec-
tion. Copyright © 2007 John Wiley & Sons, Ltd.
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at low pH values (pH 4.0 and 5.0). During another
investigation the combination of 0.0312 mg/mL of
origanum and monolaurin was cidal for H. pylori strain
ATCC 49503 (Preuss et al., 2005).
Dittrichia viscosa W. Greuter Asteraceae is a subshrub
widespread in Europe, especially in Mediterranean
areas (Devesa, 1987). This species has been used for
years in folk medicine in the treatment of gastroduo-
denal diseases (Font Quer, 1978). Some studies revealed
that the antiulcerogenic effect of D. viscosa is mainly
due to its flavonoid fraction (Grande et al., 1992; Martín
et al., 1988). In addition to the flavonoid fraction, other
authors studied the volatile oil of D. viscosa collected
in Turkey and Spain (Pérez-Alonso et al., 1996; Camacho
et al., 2000). The essential oil of D. viscosa subsp. viscosa
collected in Portugal was also subjected to studies in
order to elucidate its ability to prevent H. pylori growth
(Silva et al., 2005). The investigators concluded that the
chemical composition of the oil isolated from plants
collected in Portugal was closer to that previously
reported (Camacho et al., 2000) for the oil obtained
from plants from Spain (Province of Jaénz) and for
that from Corsica (Blanc et al., 2006), mainly in the
presence of the major components fokienol and (E)-
nerolidol. Moreover in that study, a small amount of
essential oil of D. viscosa subsp. viscosa from Portugal
was detected, for the first time, which could drastically
reduce the growth of H. pylori (Silva et al., 2005).
The main goal of the present contribution was
to determine the ability of the essential oil of the
Portuguese endemic D. viscosa subsp. revoluta and some
of its fractions to inhibit the growth of H. pylori.
METHODS
Plant material. The aerial parts of Dittrichia viscosa
subsp. revoluta were collected in the region of
Algarve, Portugal in the flowering phase, during
July–September 2002.
Isolation procedure. An essential oil sample was isolated
by water distillation for 4 h from fresh material, using a
Clevenger-type apparatus, according to the procedure
described in the European Pharmacopoeia (Anonymous,
1996). The essential oil was stored at 4 °C in the dark
prior to analysis. The yield of the essential oil was 0.3%
(v/w).
Oil fractionation. The bulk oil (2 g) was submitted
to flash chromatography (FC), silica gel 63–200 μm.
The first two fractions (F) were eluted with pentane
(F1 = 26 mg; F2 = 133 mg); two fractions were eluted
with pentane/diethyl oxide (95/5) (F3 = 48 mg; F4 =
134 mg); two fractions were eluted with pentane/diethyl
oxide (75/25) (F5 = 459 mg; F6 = 443 mg); the last two
fractions were eluted with diethyl oxide (F7 = 339 mg;
F8 = 88 mg).
Gas chromatography. Analytical GC was carried out
in a Perkin-Elmer Autosystem XL gas chromatograph
apparatus with dual FID and fused-silica capillary
columns with different stationary phases: BP-1 (poly-
methylsiloxane 50 m × 0.22 mm i.d., film thickness
0.25 μm), and BP-20 (polyethylene glycol 50 m × 0.22 mm
i.d., film thickness 0.25 μm). Carrier gas: helium at
0.8 mL/min; splitting ratio: 1:60; injection temperature:
250 °C; oven temperature programmed from 60 to
220 °C at 2 °C/min and then held isothermal (20 min);
detector temperature: 250 °C.
Gas chromatography-mass spectrometry. Analyses were
carried out in a Hewlett-Packard 6890 gas chromato-
graph fitted with a HP1 fused silica column (polydime-
thylsiloxane 30 m × 0.25 mm i.d., film thickness 0.20 μm),
interfaced with a Hewlett-Packard mass-selective detec-
tor 5973 (Agilent Technologies) operated by HP Enhanced
ChemStation software, version A.03.00. GC parameters
as described earlier; interface temperature: 250 °C; MS
source temperature: 230 °C; MS quadrupole tempera-
ture: 150 °C; ionization energy: 70 eV; ionization current:
60 μA; scan range: 35 –350 units; scan/s: 4.51.
13C-NMR. 13C-NMR spectra of the crude oil as well as
the fractions of flash chromatography were recorded
on a Bruker AC200 Fourier Transform spectro-
meter operating at 50.323 MHz, equipped with a 10 mm
probe (200 mg oil; 2 mL CDCl3; 5000 scans) or 5 mm
probe (70 mg oil; 0.5 mL CDCl3; 10 000 scans), with all
shifts referred to tetramethylsilane (TMS). 13C spectra
were recorded with the following parameters: pulse
width (PW), 5 μs [or 3 μs] (flip angle 45°); acquisi-
tion time, 1.3 s and relaxation delay (Dl), 2 s (total
recycling time, 3.3 s) for 32 K data table with a spec-
tral width (SW) of 12 500 Hz (250 ppm); CPD mode
decoupling; digital resolution, 0.763 Hz/pt. An exponen-
tial multiplication of the free induction decay with the
line broadening of 1.0 Hz was applied before Fourier
transformation.
Qualitative and quantitative analyses. The identity of
the components was achieved from their retention
indices on polar and apolar columns, determined
relative to the retention times of a series of C8-C22 n-
alkanes with linear interpolation with those of authen-
tic components included in our own laboratory database.
Acquired mass spectra were compared with reference
spectra from our own library or from literature data
(Adams, 2004; Joulain and Konig, 1998). The identity
was also determined by 13C-NMR spectroscopy, follow-
ing the methodology developed and computerized in
our laboratories (Tomi et al., 1995).
Relative amounts of individual components were
calculated based on GC peak areas without flame
ionization detector (FID) response factor correction.
Antibacterial determination. Crude essential oil and
oxygenated fractions of the oil were eluted in 2-propanol
(10%, v/v) and all concentrations were from the same
stock solution of the eluted essential oil. Essential oil
and the oxygenated fractions of the oil were incor-
porated into the Columbia agar medium (supple-
mented with 10% blood, v/v). The 2-propanol was
tested previously for antimicrobial activity and at the
concentration used no effect on bacterial viability was
registered. Helicobacter pylori strain 3, 28, 30, 40 and
147 are clinical isolates from gastric biopsies obtained
at Faro Hospital (Portugal) and belong to the Micro-
biology Laboratory of Faculty of Natural Resources
Engineering of University of Algarve. H. pylori strains
CCUG 15818, 26695 and J99 were used as laboratory
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strains. Bacterial viability was determined by the drop
method (Chen et al., 2003). Briefly, the dilutions of the
sample were done using a 96-well plate, initially 250 μL
of the sample was distributed into the first well of each
row of the microplate followed by the preparation of
10-fold serial dilutions using a multichannel pipette
(Transferpette-8, Brandtech, USA) by transferring 20 μL
from the first row into 180 μL of medium on the next
column. The inocula were homogenized by pipetting
at least 10 times and the followed dilutions were done
by repeating the process having changed pipette tips
between dilutions. Afterwards, six replicates of 10 μL
from each of the six selected dilutions were distributed
onto Columbia agar medium (supplemented with 10%
blood, v/v) at appropriate essential oil concentration.
Inocula were allowed to dry before to introduce them
in anaerobic jars (Oxoid, Basingstoke, Hampshire, UK)
in the presence of Anaerocult A pack for generation
of anaerobic conditions. The plates were incubated
during 5–7 days at 37 °C.
The MIC of the antibiotic amoxicillin was determined
by the ε-test (AB Biodisk, Sweden) in Columbia medium
supplemented with blood (10%, v/v).
RESULTS AND DISCUSSION
The identified compounds in the essential oil of D.
viscosa subsp. revoluta are indicated in Table 1, where
the components are listed in order of their elution
on the BP-1 column. The essential oil of D. viscosa
subsp. revoluta was mainly constituted by oxygenated
compounds. The fractions eluted with pentane/diethyl
oxide (75/25), that is, fraction F5 and F6 provided 459
and 443 mg, respectively; the elution with diethyl oxide
produced fractions F7 and F8 with a total mass of 339
and 88 mg, respectively. The major components present
in the oil were 3-methoxy cuminyl isobutyrate (12%),
α-cadinol (6.3%), eudesm-6-en-4α-ol (4.8%) and δ-
cadinene (4.6%). The presence of 3-methoxy cuminyl
isobutyrate was previously reported by Ascensão et al.
(1999) in the oil of D. viscosa subsp. revoluta repre-
senting 15% of the total oil of the inflorescences. The
presence of costic acid, isocostic acid and 4-en-ilicic
acid were reported by Blanc et al. (2006, 2005, 2004)
for D. viscosa ssp. viscosa and Inula graveolens
from Corsica. The direct quantification of these three
Table 1. Composition of the essential oil of D. viscosa subsp. revoluta. Components listed according to their
elution on the BP1 column
Component RIa RIb Percentage in sample
1,8-Cineole 1021 1211 0.5
Linalool 1083 1543 0.4
p-Mentha1,5-dien-8ol 1145 1722 0.4
Terpinen-4ol 1162 1599 0.2
p-Mentha1(7),2-dien-8-ol 1169 1780 0.5
Bornyl acetate 1269 1577 0.5
α-Cubebene 1349 1453 0.1
α-Ylangene 1372 1479 0.4
α-Copaene 1377 1488 0.7
α-Gurjunene 1411 1525 0.3
trans-Caryophyllene 1419 1593 1.0
β-Copaene 1426 1586 0.1
allo-Aromadendrene 1459 1640 0.4
γ-Muurolene 1471 1683 0.7
α-Amorphene 1475 1683 0.8
Bicyclosesquiphellandrene 1488 nd 0.5
α-Muurolene 1494 1719 1.4
γ-Cadinene 1508 1756 2.4
cis-Calamenene+trans-Calamenene 1511 1832 0.9
δ-Cadinene 1517 1756 4.6
α-Cadinene 1530 1789 0.4
Caryophyllene oxide 1573 1984 1.1
Eudesm-6-en-4α-ol 1608 2165 4.8
γ-Eudesmol 1622 2171 1.1
T-Cadinol 1630 2171 2.1
T-Muurolol 1630 2186 2.7
Caryophylla-4(14),8(15)-diene-5α-ol 1630 2298 1.1
α-Eudesmol 1643 2220 1.4
α-Cadinol 1643 2233 6.3
Cadalene 1656 2224 0.2
3-Methoxy cuminyl isobutyrate 1682 2271 12.0
Pentacosane nd 2499 0.2
Isocostic acid nd nd
Costic acid nd nd
4-en-Ilicic acid nd nd
a RI: retention indices measured on apolar column (BP-1).
b RI: retention indices measured on polar column (BP-20).
nd: not determined.
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eudesman-type acids by GC was not performed due to
their relative low volatility, being necessary to proceed
to a previous derivatization in order to transform them
in the corresponding methyl esters prior to the GC
analysis (Grande et al., 1992; Blanc et al., 2005).
Regarding this, such acids were identified by 13C-NMR.
The fractions used for the determination of anti-H.
pylori activity were those mainly composed of oxygen-
ated compounds not only by their highest mass ob-
tained but also by the oxygenated components that are
generally responsible for biological activities, namely
fraction 4, 5, 6 and 7. 3-Methoxy cuminyl isobutyrate
was the major component detected in fraction F5
constituting about 40% of the fraction. In fraction 6,
one component not identified constituted 25% of
the total oil, followed by T-cadinol, T-muurolol and
caryophylla-4(14),8(15)-diene-5α-ol that reached a
percentage of 18% and finally eudesm-6-en-4α-ol (10%).
The fraction F7 was mainly constituted by α-cadinol
and α-eudesmol with a total percentage of 31%. The
olefinic fractions F1 and F2 eluted by pentane were
mainly composed of α-copaene (34%), γ-cadinene (19%),
α-ylangene (15%), α-gurjunene (14%), α-muurolene
(10%) and δ-cadinene (10%).
Crude essential oil of Dittrichia viscosa subsp. revoluta
demonstrated to have anti-Helicobacter activity deter-
mined against the laboratory strain CCUG 15 818. At
a concentration of 0.33 μL/mL the initial population
of 8.52 ± 0.30 log10 cfu/mL was reduced to 7.67 ±
0.22 log10 cfu/mL.
Susceptibility of H. pylori strain CCUG 15 818 to all
oxygenated fractions tested; F4, F5, F6 and F7 was
observed. However, fraction 5, mainly constituted of
3-methoxy cuminyl isobutyrate, showed the highest
activity against the seven strains used, followed by frac-
tion F7 mainly composed of α-cadinol and α-eudesmol.
Anti-Helicobacter activity of the two active fractions is
represented in Fig. 1. H. pylori strain CCUG 15 818
was the most susceptible; at a concentration of 0.025 μL/
mL no growth was registered. H. pylori strains J99 and
strain 3 were middle resistant. At a concentration of
0.03 μL/mL the initial population of strains J99 (9.61 ±
0.07 cfu/mL) and strain 3 (9.77 ± 0.28 log10 cfu/mL) were
reduced 1 log. At the highest concentration no recov-
ery of cells was registered. The most resistant strains
were strain 26 695 and strain 147. At the highest con-
centration tested (0.035 μL/mL) the initial population
of strain 26 695 (9.02 ± 0.76 log10 cfu/mL) was reduced
4 log, whereas the initial population of strain 147
(9.04 ± 0.07 log10 cfu/mL) was reduced 6 log. Fraction 7
demonstrated an anti-Helicobacter pylori activity only
against the strain H. pylori CCUG 15 818 (Fig. 1). At
a concentration of 0.025 μL/mL the initial population
of this strain (9.01 ± 0.04 log10 cfu/mL) was reduced 5 log.
The other strains did not experience a significant re-
duction (Fig. 1). Regarding the susceptibility of H. pylori
strains to the antibiotic amoxicillin the MIC value for
H. pylori strain J99, CCUG 15 818, 147, was 0.50 μg/
mL, 0.16 μg/mL, 0.16 μg/mL and H. pylori strains 3,
28 and 40 were resistant to higher than 256 μg/mL. It is
interesting to verify that the H. pylori strains 3 and 28
Figure 1. Susceptibility of Helicobacter pylori strains CCUG
15 818, 26 695, J99, 3, 28 and 40 to the oxygenated fractions
5 (A) and 7 (B) of the essential oil of Dittrichia viscosa subsp.
revoluta. Data are the mean of three independent experiments.
Bars represent the standard deviation.
that are highly resistant to the antibiotic amoxicillin
are susceptible to oxygenated fraction F5.
In spite of chemical differences detected in both
subspecies, our previous results on the determina-
tion of the antimicrobial activity of Dittrichia viscosa
subsp. viscosa essential oil indicated a specific activity
of this essential oil against H. pylori but a null activity
against an important foodborne pathogen Listeria
monocytogenes (Silva et al., 2005). The use of the
essential oil of Dittrichia viscosa subsp. viscosa and
D. viscosa subsp. revoluta may greatly contribute to an
efficient control of this bacterial pathogen that is spread
amongst the world population and for which the mode
of transmission is still controversial. Moreover due to
the increase of the multiresistance pattern and also the
increasing tendency of the public to consume ‘green
products’ the use of these types of compounds will
greatly help to combat this infection accompanied
by consumer confidence and support which plays an
important role to the therapy success.
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